Naoko Aragane

Nabeshima, 8498501, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Cancer of Unknown Primary Most Suggestive of Colorectal Origin With Microsatellite Instability-high Status and High Tumor Mutation Burden Including NTRK Fusion.

Cancer of Unknown Primary Most Suggestive of Colorectal Origin With Microsatellite Instability-high Status and High Tumor Mutation Burden Including NTRK Fusion.

Journal: Cancer diagnosis & prognosis

Published: December 24, 2025

Integrated analysis of older adults and patients with renal dysfunction in the IMpower130 and IMpower132 randomized controlled trials for advanced non-squamous non-small cell lung cancer.

Integrated analysis of older adults and patients with renal dysfunction in the IMpower130 and IMpower132 randomized controlled trials for advanced non-squamous non-small cell lung cancer.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: March 21, 2024

Dysautonomia associated with immune checkpoint inhibitors.

Dysautonomia associated with immune checkpoint inhibitors.

Journal: Journal of neurology

Published: January 25, 2023

Real-World Data Analysis of Pembrolizumab Monotherapy for NSCLC Using Japanese Postmarketing All-Case Surveillance Data.

Real-World Data Analysis of Pembrolizumab Monotherapy for NSCLC Using Japanese Postmarketing All-Case Surveillance Data.

Journal: JTO clinical and research reports

Published: August 11, 2022

Clinical utility of comprehensive genomic profiling in Japan: Result of PROFILE-F study.

Clinical utility of comprehensive genomic profiling in Japan: Result of PROFILE-F study.

Journal: PloS one

Published: November 04, 2021

ALDH2 polymorphism rs671 is a predictor of PD-1/PD-L1 inhibitor efficacy against thoracic malignancies.

ALDH2 polymorphism rs671 is a predictor of PD-1/PD-L1 inhibitor efficacy against thoracic malignancies.

Journal: BMC cancer

Published: February 19, 2021

Multiplex gene-panel testing for lung cancer patients.

Multiplex gene-panel testing for lung cancer patients.

Journal: Pathology international

Published: June 24, 2020

Mechanisms of acquired resistance to afatinib clarified with liquid biopsy.

Mechanisms of acquired resistance to afatinib clarified with liquid biopsy.

Journal: PloS one

Published: August 27, 2018

Phase II trial of weekly nab-paclitaxel for previously treated advanced non-small cell lung cancer: Kumamoto thoracic oncology study group (KTOSG) trial 1301.

Phase II trial of weekly nab-paclitaxel for previously treated advanced non-small cell lung cancer: Kumamoto thoracic oncology study group (KTOSG) trial 1301.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: April 05, 2016

Phase II trial of erlotinib for Japanese patients with previously treated non-small-cell lung cancer harboring EGFR mutations: results of Lung Oncology Group in Kyushu (LOGiK0803).

Phase II trial of erlotinib for Japanese patients with previously treated non-small-cell lung cancer harboring EGFR mutations: results of Lung Oncology Group in Kyushu (LOGiK0803).

Journal: Japanese journal of clinical oncology

Published: April 20, 2013

Phosphaturic mesenchymal tumor, nonphosphaturic variant, causing fatal pulmonary metastasis.

Phosphaturic mesenchymal tumor, nonphosphaturic variant, causing fatal pulmonary metastasis.

Journal: Human pathology

Published: February 01, 2013

Efficacy of aprepitant for quality of life of outpatients receiving moderately emetogenic chemotherapy

Efficacy of aprepitant for quality of life of outpatients receiving moderately emetogenic chemotherapy

Journal: Gan to kagaku ryoho. Cancer & chemotherapy

Published: June 19, 2012

Showing 1-12 of 14

Last Updated: 09/26/2026